Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
Submitted by
admin
on May 28, 2013 - 8:14am
Source:
Seeking Alpha
News Tags:
BioDelivery Sciences
Acadia
Amarin
Keryx
Insmed
opiod addiction
Headline:
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
Do Not Allow Advertisers to Use My Personal information
